CSSI PROFILE

January 30, 2023

OUR NEW PROFILE IS: (OTC: CSSI)

_______________

CSSI COMPLETES ACQUISITION OF FLORIDA BASED, PRIME DENTAL LAB, LLC

COSTAS REPORTS 2022 3RD QUARTER REVENUE AND EXIT FROM SHELL STATUS

THE ACQUISITION OF PRIME DENTAL DELIVERS MORE THAN TEN YEARS OF EXPERIENCE AND 2021 UNAUDITED GROSS REVENUE IN EXCESS OF $600,000.

______________________________

Hello Everyone,

The market just opened seconds ago and we have CSSI on our radar for today.

This one is extremely thin and has a very limited history so make sure you are watching it very close this morning.

It is a company that you want to get on you’re radar right now as things look like they are still in it’s infancy but progressing forward as you follow the press releases below.

CSSI has developed branding and a detailed business plan to facilitate the acquisition of small to medium sized dental labs, of which there are thousands in the United States. Similar models have been extensively used in the medical clinic and dental clinic industries over the past 30 years, but dental laboratories remain highly fragmented. “Consolidating small, privately owned labs into larger, regionally managed facilities will bring economies of scale, and enhance competitiveness and product quality in regional markets.” said Costas CEO, James Brooks.

SDL has been actively looking for dental lab owners interested in selling their labs over the recent months. With the recently acquired consolidation model and ready to launch branding, the Company expects to identify several suitable acquisition targets in the coming weeks and months, with the goal of becoming one of the largest operators in the industry. “There’s no faster way to grow than through acquisition, and this industry, in particular, remains unsophisticated in the public sector.”, added Brooks.

Consolidation of this industry, currently represented by 7,000+ privately owned businesses, is now the Company’s focus. The acquired business model will allow the Company to quickly identify suitable targets, to build and scale in order to become regionally competitive. In the process, the Company will be positioning itself as a leader in setting new standards for the dental lab industry.

Acquiring cash flowing, and profitable businesses with a financial track record, is Standard Dental Labs business strategy. The dental lab industry as a whole is estimated to be a $10B market in the US alone in 2022 (source: Grandview Research, Aug. 2021), but is growing steadily.

As you read the press releases below you will see the progression of the business plan start to unfold from the acquisition of a company, to their first revenue generating acquisition to removal of shell status and a planned uplisting to a higher quality exchange.

COSTAS, INC. CLOSES AGREEMENT TO ACQUIRE ASSETS OF STANDARD DENTAL LABS INC

ORLANDO, FL / ACCESSWIRE / May 6, 2022 / Costas, Inc. (OTCMKTS:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. As previously announced, on February 28th, 2022, the shareholders of Standard Dental Labs Inc. (“SDL”) voted unanimously in favor of accepting an offer from CSSI to acquire its assets. The Company is pleased to announce the parties have entered into a formal acquisition agreement, which is expected to close in the coming days. The completion of this acquisition will cement the Company’s entry into the dental lab industry, paving the way for future acquisitions and consolidations in the industry.

The business model acquired from SDL, a company incorporated in Wyoming in 2019, and controlled by Mr. Brooks, the Company’s CEO, has developed branding and a detailed business plan to facilitate the acquisition of small to medium sized dental labs, of which there are thousands in the United States. Similar models have been extensively used in the medical clinic and dental clinic industries over the past 30 years, but dental laboratories remain highly fragmented. “Consolidating small, privately owned labs into larger, regionally managed facilities will bring economies of scale, and enhance competitiveness and product quality in regional markets.” said Costas CEO, James Brooks.

COSTAS, INC. COMPLETES ACQUISITION OF FLORIDA BASED DENTAL LAB, PRIME DENTAL LAB, LLC

ORLANDO, FL / ACCESSWIRE / August 16, 2022 / Costas, Inc. (OTC PINK:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. The Board of Directors of CSSI is pleased to announce the completion of a definitive agreement to acquire Prime Dental Lab, LLC. (“Prime Dental”), an Orlando-based dental lab in operation since 2012, under the ownership and management of Mr. John Kim. The acquisition of Prime Dental delivers more than ten years of experience and 2021 unaudited gross revenue in excess of $600,000.

The opportunity to acquire Prime Dental follows the May 6, 2022, acquisition of certain assets of Standard Dental Labs Inc. (“SDL”), a company founded by CSSI CEO, James Brooks. Now operating under the DBA SDL, CSSI is currently searching for dental lab owners that have struggled to find an exit from the industry, intending to retire or who lack the resources to remain competitive. Among the assets acquired from SDL was the comprehensive business plan and roll up strategy aimed to facilitate the acquisition of these small to medium-sized dental labs, of which there are thousands in the United States.

On August 15, 2022, following a due diligence process, CSSI and Prime Dental executed an Asset Purchase Agreement. Total consideration of $700,000.00 will be paid to the shareholders of Prime Dental in a combination of cash and registered shares for the assets, which includes all equipment, the client base, and associated revenue. Shares will be escrowed over two years, paid in quarterly installments. Although both parties have executed the agreement, it will not be ratified until the submission of a Form S-1 Registration with the Securities and Exchange Commission and receipt of notice of effect.

The acquisition of Prime Dental is the latest in a series of dental labs the Company plans to acquire in the coming years. CSSI’s mandate is to acquire cash-flowing, profitable businesses with strong financial track records and consolidate these operations, achieving operational efficiencies and enhancing the bottom line. Prime Dental brings immediate revenue-generating operations, and CSSI plans to facilitate access to previously inaccessible cutting-edge equipment, kickstarting growth.

In 2022, the dental lab industry is estimated to be a $10B market in the US (source: Grandview Research, Aug. 2021) and continues to grow. Therefore, consolidation within the industry, represented by 7,000+ privately owned businesses, is the Company’s focus. In the process, Costas Inc. will be positioning itself as a leader in setting new standards for the dental lab industry. It expects to continue identifying suitable acquisitions in the coming weeks and months, focusing on becoming one of the largest operators in the industry.

COSTAS REPORTS 2022 3RD QUARTER REVENUE AND EXIT FROM SHELL STATUS

ORLANDO, FL / ACCESSWIRE / November 30, 2022 / Costas, Inc. (OTC PINK:CSSI) (“CSSI” or “the Company”), doing business as Standard Dental Labs Inc., reports that it has recorded 3rd quarter gross revenues of $44,770 in its most recent quarterly financial report. The third quarter revenues are the result of the recent acquisition of operating assets, including customer contracts and lab equipment, from Prime Dental Labs with an effective date of September 1, 2022. The reported revenues are the Company’s first recorded revenues under new management from planned dental lab acquisitions and operations.

Now that Standard Dental Labs expects to report ongoing monthly revenue, the Company has also filed a supplemental notice to shareholders notifying them that the Company is no longer a “Shell Company”, as defined under Rule 405 of the US Securities Act of 1933 (“Rule 405”). The removal of the “Shell” symbol on the OTCMarkets landing page, once removed by OTCMarkets, will be a significant milestone for Costas, Inc., and evidence of the Company’s continuing effort to improve corporate governance and disclosure compliance for shareholders. The determination to remove Shell status is at the sole discretion of OTCMarkets, and is not an indicator of any compliance issues.

The Company will continue to make efforts to acquire more dental labs in the Orlando, Florida region, with the goal of consolidating those labs into one, larger location where we will be able to capitalize on the economies of scale and joint experience.

In 2022, the dental lab industry is estimated to be a $10B market in the US (source: Grand View Research, Aug. 2021) and continues to grow. Therefore, consolidation within the industry, represented by 7,000+ privately owned businesses, is the Company’s focus. In the process, the Company will be positioning itself as a leader in setting new standards for the dental lab industry. It expects to continue identifying suitable acquisitions in the coming weeks and months, focusing on becoming one of the largest operators in the industry.

COSTAS, INC. ENGAGES INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, PROGRESSING CORPORATE ROADMAP

ORLANDO, FL / ACCESSWIRE / August 24, 2022 / Costas, Inc. (OTC PINK:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. The Company is pleased to report that it has recently engaged an Independent Registered Public Accounting Firm to audit the financial results for Costas, Inc. (OTCMKTS: CSSI) and Prime Dental Lab LLC. for the most recent two fiscal years ended December 31, 2021 and 2020, and the six-month comparative interim periods ended June 30, 2022 and 2021. As previously announced, on August 15, 2022, Costas entered into an agreement to purchase the assets of Prime Dental Lab LLC, including its client base and revenue (the “Asset Purchase Agreement”).

The Independent PCAOB Registered Public Accounting Firm will audit both companies according to US GAAP; including a review of revenue recognition policies in accordance with ASC 606.

The objective for Costas is to become a fully reporting issuer with a class of securities registered with the Securities and Exchange Commission (“SEC”), while substantially growing revenue generating operations via the acquisition of central labs with existing manufacturing capabilities. The Company expects to complete the audits and file a Form S-1 Registration with the SEC. Within the next few months, CSSI hopes to be listed on the OTCQB and maintain business as a fully reporting issuer.

NEWS

Costas Reports 2022 3rd Quarter Revenue and Exit from Shell StatusPRESS RELEASE | 11/30/2022

Costas, Inc. Engages Independent Registered Public Accounting Firm, Progressing Corporate RoadmapPRESS RELEASE | 08/24/2022

Costas, Inc. Completes Acquisition of Florida Based Dental Lab, Prime Dental Lab, LLCPRESS RELEASE | 08/16/2022

Costas, Inc. Closes Agreement To Acquire Assets of Standard Dental Labs Inc.PRESS RELEASE | 05/06/2022

Costas, Inc. Makes Offer to Purchase Standard Dental Labs Inc.PRESS RELEASE | 03/02/2022

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF TWENTY TWO THOUSAND USD BY A THIRD PARTY, AWARENESS CONSULTING NETWORK LLC FOR A ONE DAY CSSI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS, LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. DEDICATED INVESTORS LLC HAS NOT BEEN COMPENSATED FOR THIS EMAIL. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.